Skip to main content
. 2016 Jan 1;2(1):36–42.

Table 2.

Sexual behaviour, STI, hepatitis serology and IDU by sexual orientation and gender.

MSM
(N=153)
n (%)
Non-MSM male
(N=334)
n (%)
Female
(N=417)
n (%)
Total
(N=904) 2
n (%)
P-value
HIV status of regular sex partner
 Positive 32(26.4) 106(37.7) 266(68.7) 404(51.2) <0.001
 Negative/unknown 89(73.6) 175(62.3) 121(31.3) 385(48.8)
Multiple sex partners in last 30 days 1
 Yes 20(29.9) 5(2.8) 7(2.6) 32(6.2) <0.001
 No 47(70.1) 175(97.2) 260(97.4) 482(93.8)
Received money for sex in last 30 days 1
 Yes 3(4.5) 0(0.0) 2(0.7) 5(1.0) 0.0146
 No 64(95.5) 182(100) 267(99.3) 513(99.0)
Any STI symptoms
 Yes 9(5.9) 22(6.6) 94(22.5) 125(13.8) <0.001
 No 144(94.1) 312(93.4) 323(77.5) 779(86.2)
History of IDU
 Yes 15(9.8) 182(54.5) 25(6.0) 222(24.6) <0.001
 No 138(90.2) 152(45.5) 392(94.0) 682(75.4)
Syphilis serology
 Positive 31(20.3) 22(6.7) 6(1.5) 59(6.6) <0.001
 Negative 122(79.7) 306(93.3) 407(98.5) 835(93.4)
HBsAg
 Positive 20(13.2) 50(15.1) 31(7.5) 101(11.3) 0.004
 Negative 131(86.8) 282(84.9) 383(92.5) 796(88.7)
Anti-HCV
 Positive 18(11.9) 183(55.3) 53(12.8) 254(28.3) <0.001
 Negative 133(88.1) 148(44.7) 361(87.2) 642(71.7)
HIV viral load(copies/mL)
 0–999 7(4.6) 39(11.7) 60(14.4) 106(11.7) <0.001
 1000–9999 23(15.0) 81(24.3) 144(34.5) 248(27.4)
 10,000–99,999 92(60.1) 154(46.1) 163(39.1) 409(45.2)
 ≥100,000 31(20.3) 60(18.0) 50(12.0) 141(15.6)
Recently diagnosed HIV infection
 Yes 64(41.8) 49(14.7) 48(11.5) 161(17.8) <0.001
 No 89(58.2) 285(85.3) 369(88.5) 743(82.2)

STI: sexually transmitted infections; IDU: injection drug use; MSM: men who have sex with men.

1

Among those who reported sex in last 30 days. Some participants did not answer all risk-behaviour questions.

2

Some factors have lower totals due to missing data.